• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达沃市HIV暴露前预防的回顾性研究

A Retrospective Review on HIV Pre-Exposure Prophylaxis in Davao City.

作者信息

Ebe Angel Mae A, Gucila Chriszle Anne T, Esponilla Aj G, Canja Jayson B, Gabucan Von Jay Maico G

机构信息

College of Pharmacy and Chemistry, University of the Immaculate Conception, Davao City 8000, Philippines.

出版信息

Innov Pharm. 2024 May 31;15(2). doi: 10.24926/iip.v15i2.6228. eCollection 2024.

DOI:10.24926/iip.v15i2.6228
PMID:39166143
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11333092/
Abstract

: Evaluating the adherence to HIV Pre-Exposure Prophylaxis (PrEP) is essential for increasing its utilization and decreasing the risk of HIV transmission among Davao City's vulnerable groups. : The research method utilized in the study is a quantitative, retrospective, descriptive research design. This method was employed to retrospectively review the de-identified data, which involved the fill and refill dates of PrEP and tablets supplied, to calculate the Proportion of Days Covered (PDC) among individuals in Davao City from January 2021 to December 2023. The study also included some demographic characteristics such as age and gender. : From 178 data entries collected, the age group of 25 to 34 years old was found to have the highest HIV PrEP use (52.25%), followed by those between 18 to 24 (30.90%), 35 to 44 (13.48%), and 45 years old and older (3.37%). Out of 178, only 2 clients were female. Furthermore, 73.60% of the 178 entries in the pharmacy records were identified to be taking PrEP daily. Descriptive statistics showed that the frequency of adherent clients across the years were 36.36%, 44.74% and 38.46%, respectively. Furthermore, the average PDC through the years was found to be 70.13%, 80.48%, and 72.8%. Age did not significantly affect adherence to PrEP during the years investigated (p-values > 0.05). : Adherence to PrEP improved consistently in 2022 but declined in 2023, showing erratic adherence rates. Furthermore, adherence to HIV PrEP in Davao City was found to be suboptimal and while there are clients who are adherent, many are not. The results emphasize the need for targeted interventions and suggest that other socio-behavioral factors may play a role in this. To improve adherence and prevent HIV contractions, both short-term actions like public education campaigns about HIV PrEP and long-term plans like incorporating PrEP into the community pharmacies can be contributive.

摘要

评估对艾滋病毒暴露前预防(PrEP)的依从性对于提高其使用率和降低达沃市弱势群体中的艾滋病毒传播风险至关重要。

本研究采用的研究方法是定量、回顾性、描述性研究设计。该方法用于回顾性审查去识别化的数据,其中包括PrEP的填充和再填充日期以及提供的药片数量,以计算2021年1月至2023年12月期间达沃市个体的药物覆盖天数比例(PDC)。该研究还包括一些人口统计学特征,如年龄和性别。

在收集的178条数据记录中,25至34岁年龄组的艾滋病毒PrEP使用率最高(52.25%),其次是18至24岁的人群(30.90%)、35至44岁的人群(13.48%)以及45岁及以上的人群(3.37%)。在178人中,只有2名女性客户。此外,药房记录中的178条记录中有73.60%被确定为每天服用PrEP。描述性统计显示,各年份依从性客户的频率分别为36.36%、44.74%和38.46%。此外,各年份的平均PDC分别为70.13%、80.48%和72.8%。在所调查的年份中,年龄对PrEP的依从性没有显著影响(p值>0.05)。

2022年对PrEP的依从性持续改善,但在2023年有所下降,显示出不稳定的依从率。此外,发现达沃市对艾滋病毒PrEP的依从性不理想,虽然有一些客户依从,但许多人并不依从。结果强调了有针对性干预的必要性,并表明其他社会行为因素可能在其中起作用。为了提高依从性并预防艾滋病毒感染,开展关于艾滋病毒PrEP的公众教育活动等短期行动以及将PrEP纳入社区药房等长期计划都可能有所帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a43/11333092/99781d6eabf1/21550417-15-02-6228_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a43/11333092/2758723dcbbf/21550417-15-02-6228_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a43/11333092/99781d6eabf1/21550417-15-02-6228_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a43/11333092/2758723dcbbf/21550417-15-02-6228_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a43/11333092/99781d6eabf1/21550417-15-02-6228_Fig2.jpg

相似文献

1
A Retrospective Review on HIV Pre-Exposure Prophylaxis in Davao City.达沃市HIV暴露前预防的回顾性研究
Innov Pharm. 2024 May 31;15(2). doi: 10.24926/iip.v15i2.6228. eCollection 2024.
2
Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.在肯尼亚开展的一项混合方法研究中,在公立诊所开始接受 PrEP 的患者中,在私人药店选择续开 HIV PrEP 的比例较低。
BMC Health Serv Res. 2024 May 11;24(1):618. doi: 10.1186/s12913-024-10995-0.
3
Medication Adherence in a Nationwide Cohort of Veterans Initiating Pre-exposure Prophylaxis (PrEP) to Prevent HIV Infection.全国范围内开始使用暴露前预防(PrEP)来预防 HIV 感染的退伍军人中的药物依从性。
J Acquir Immune Defic Syndr. 2018 Mar 1;77(3):272-278. doi: 10.1097/QAI.0000000000001598.
4
Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.在肯尼亚和乌干达进行人群 HIV 检测后提供的暴露前预防措施的接受、参与和坚持情况:来自 SEARCH 研究的观察性数据的 72 周中期分析。
Lancet HIV. 2020 Apr;7(4):e249-e261. doi: 10.1016/S2352-3018(19)30433-3. Epub 2020 Feb 19.
5
Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.2015 年至 2017 年,在美国,对 7148 名 PrEP 用户进行的全国性样本研究显示,有超过 2 年时间坚持使用 HIV 暴露前预防药物。
J Int AIDS Soc. 2019 Feb;22(2):e25252. doi: 10.1002/jia2.25252.
6
Pre-exposure Prophylaxis Uptake, Adherence, and Persistence: A Narrative Review of Interventions in the U.S.暴露前预防措施的接受度、依从性和持久性:美国干预措施的叙述性综述
Am J Prev Med. 2021 Nov;61(5 Suppl 1):S73-S86. doi: 10.1016/j.amepre.2021.04.036.
7
Dynamicity of HIV Pre-exposure Prophylaxis Usage Pattern and Association with Executed Adherence in MSM: An Implementation Study in Hong Kong.男男性行为者中HIV暴露前预防用药模式的动态变化及其与实际依从性的关联:香港的一项实施研究
AIDS Behav. 2024 Apr;28(4):1327-1344. doi: 10.1007/s10461-023-04167-0. Epub 2023 Sep 29.
8
Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.肯尼亚独立模型用于提供口服 HIV 暴露前预防:一项单臂、前瞻性试点评估。
J Int AIDS Soc. 2023 Jun;26(6):e26131. doi: 10.1002/jia2.26131.
9
The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya.肯尼亚基于药房的口服 HIV 暴露前预防方案提供模式的保真度。
J Acquir Immune Defic Syndr. 2023 Aug 15;93(5):379-386. doi: 10.1097/QAI.0000000000003208.
10
Imperfect adherence in real life: a prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men - a prospective cohort study in Taiwan.现实生活中的不完美依从:从预防有效性角度看男男性行为者日常和事件驱动的 HIV 暴露前预防用药依从性 - 台湾一项前瞻性队列研究。
J Int AIDS Soc. 2021 May;24(5):e25733. doi: 10.1002/jia2.25733.

本文引用的文献

1
Adherence and persistence of HIV pre-exposure prophylaxis use in the United States.美国 HIV 暴露前预防用药的坚持和持久性。
Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5729. doi: 10.1002/pds.5729. Epub 2023 Nov 20.
2
Pharmacist-Led Management of HIV PrEP Within the Veterans Health Administration.退伍军人健康管理局内由药剂师主导的HIV暴露前预防管理
Fed Pract. 2023 Jul;40(7):218-223. doi: 10.12788/fp.0379. Epub 2023 May 22.
3
Barriers to Pre-Exposure Prophylaxis (PrEP) use for HIV: an integrative review.预防 HIV 感染的暴露前预防(PrEP)使用障碍:综合评价。
Rev Bras Enferm. 2023 Jun 26;76(3):e20210963. doi: 10.1590/0034-7167-2021-0963. eCollection 2023.
4
The State of the HIV Epidemic in the Philippines: Progress and Challenges in 2023.菲律宾的艾滋病疫情状况:2023年的进展与挑战
Trop Med Infect Dis. 2023 Apr 30;8(5):258. doi: 10.3390/tropicalmed8050258.
5
Adherence to Pre-Exposure Prophylaxis (PrEP) among Men Who Have Sex with Men (MSM) in Portuguese-Speaking Countries.葡语国家男男性行为者(MSM)对暴露前预防(PrEP)的依从性。
Int J Environ Res Public Health. 2023 Mar 10;20(6):4881. doi: 10.3390/ijerph20064881.
6
What do young people know about HIV? Results of a cross sectional study on 18-24-year-old students.年轻人对 HIV 了解多少?一项针对 18-24 岁学生的横断面研究结果。
J Prev Med Hyg. 2022 Dec 31;63(4):E541-E548. doi: 10.15167/2421-4248/jpmh2022.63.4.2555. eCollection 2022 Dec.
7
PrEP-related stigma and PrEP use among gay, bisexual and other men who have sex with men in Ontario and British Columbia, Canada.加拿大安大略省和不列颠哥伦比亚省男同性恋、双性恋和其他男男性行为者中的与 PrEP 相关的耻辱感和 PrEP 使用情况。
AIDS Res Ther. 2022 Oct 27;19(1):49. doi: 10.1186/s12981-022-00473-0.
8
Estimating proportion of days covered (PDC) using real-world online medicine suppliers' datasets.使用真实世界在线药品供应商数据集估算覆盖天数比例(PDC)。
J Pharm Policy Pract. 2021 Dec 29;14(1):113. doi: 10.1186/s40545-021-00385-w.
9
Underlying factors related to HIV/AIDS prevention: investigating the willingness to take pre-exposure prophylaxis among men-who-have-sex-with-men in Germany.与 HIV/AIDS 预防相关的潜在因素:调查德国男男性行为者中使用暴露前预防的意愿。
AIDS Res Ther. 2021 Sep 17;18(1):61. doi: 10.1186/s12981-021-00386-4.
10
Factors influencing pre-exposure prophylaxis uptake among current users: A qualitative study.影响当前使用者接受暴露前预防的因素:一项定性研究。
J HIV AIDS Soc Serv. 2020;19(3):252-262. doi: 10.1080/15381501.2020.1810838. Epub 2020 Aug 27.